© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#AIDS 2016
Click Here for More Conferences
Click Here for IAS Online
HIV: The Basics

Undetectable Meant Zero HIV Transmissions After 89,000 Condomless Sex Acts

The newly released PARTNER2 study documented 77,000 condomless anal sex acts between mixed-HIV-status men; Opposites Attract had 12,000.

What If the New Experimental HIV Vaccine Cuts Risk by Only Half?

With a major new HIV vaccine trial under way, cautious optimism is stirring that the vaccine will prove effective enough for a rollout.

Sustiva (Efavirenz) Is Apparently Linked to Risk of Suicide in START Trial

The major trial compared those starting HIV treatment immediately and those waiting till their CD4 counts dropped below 200.

Decline in New HIV Infections Stalls Worldwide, Reverses Course in Some Areas

UNAIDS sounds the alarm about this troubling shift in a once hopeful trend.

Zero HIV Transmissions in Major San Francisco PrEP Program

Even though higher proportions of those making later clinic visits reported more recent condomless sex, the whole group is still HIV free.

A Community Statement on Access to HIV Treatment and Prevention

8 HIV/AIDS groups launched the initiative. Now you can read, sign and share it.

PrEP-Related Bone Loss Is Reversible

Among young men on Truvada as PrEP, bone loss stabilizes after first year and reverses after stopping.

Great Success for South Africa in Preventing Mother-to-Child HIV Transmission

Just 4 percent of children born to HIV-positive mothers contract the virus by 18 months of age.

The Big News From the 2016 International AIDS Conference

A roundup of the major presentations on HIV science at the international conference held July 22 to 28 outlines many exciting developments.

Hepatitis C Treatment Epclusa Works Well in Those With HIV

The cure rate for Gilead’s new treatment is comparable to what has been seen in people who have only hep C.

What Determines Higher PrEP Adherence Among Black Gay and Bi Men?

A new study examines factors that predicted which black men who have sex with men (MSM) would better stick with the daily Truvada regimen.

WATCH: #TreatmentforAll’s New 10-Minute Documentary

See what happens when people affected by HIV gain access to treatment.

A New Major HIV Vaccine Trial Is a Go

The Phase IIb/III HVTN 702 trial will begin enrollment in southern Africa in the fall.

Nations Advance Toward UNAIDS HIV Treatment Targets

But will there be enough money to keep pushing the dial?

Another Study Shows No HIV Transmission From Undetectable Partners

The final results of the HPTN 052 study of mixed-HIV-status, opposite-sex partners are in.

Is The Global HIV Movement Keeping Up With Young People?

Constantly adapting the way that the response tries to reach young people is key.
Advertisement
Newsfeed
Treatment News
Features
Opinions